Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial

Archives of Internal Medicine
Massimo ImazioRita Trinchero


Colchicine seems to be a good drug for treating recurrences of pericarditis after conventional treatment failure, but no clinical trial has tested the effects of colchicine as first-line drug for the treatment of the first recurrence of pericarditis. A prospective, randomized, open-label design was used to investigate the safety and efficacy of colchicine therapy as adjunct to conventional therapy for the first episode of recurrent pericarditis. Eighty-four consecutive patients with a first episode of recurrent pericarditis were randomly assigned to receive conventional treatment with aspirin alone or conventional treatment plus colchicine (1.0-2.0 mg the first day and then 0.5-1.0 mg/d for 6 months). When aspirin was contraindicated, prednisone (1.0-1.5 mg/kg daily) was given for 1 month and then was gradually tapered. The primary end point was the recurrence rate. Intention-to-treat analyses were performed by treatment group. During 1682 patient-months (mean follow-up, 20 months), treatment with colchicine significantly decreased the recurrence rate (actuarial rates at 18 months were 24.0% vs 50.6%; P = .02; number needed to treat = 4.0; 95% confidence interval 2.5-7.1) and symptom persistence at 72 hours (10% vs 31%; P = .03...Continue Reading

Associated Clinical Trials


Nov 1, 2007·Future Cardiology·Massimo Imazio, Rita Trinchero
Jan 16, 2014·Current Atherosclerosis Reports·Stefan M NidorfPeter L Thompson
May 5, 2012·Women's Health·Massimo Imazio, Antonio Brucato
Apr 3, 2010·The Open Cardiovascular Medicine Journal·Sahru YükselArmen Yuri Gasparyan
Dec 31, 2010·World Journal of Cardiology·Paul FarandNicholas Tzouannis
Jan 29, 2008·Current Treatment Options in Cardiovascular Medicine·Geoffrey C Clare, Richard W Troughton
Oct 13, 2011·Current Treatment Options in Cardiovascular Medicine·Dina M Sparano, R Parker Ward
Feb 9, 2012·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Luca CantariniMassimo Imazio
Dec 17, 2009·Rheumatology International·Pawan HariLuis Afonso
Mar 26, 2011·Rheumatology International·Z Birsin Ozçakar, Fatoş Yalçınkaya
Feb 5, 2009·European Heart Journal·Massimo ImazioYehuda Adler
Sep 2, 2011·Acta chirurgica Iugoslavica·Arsen D RistićBernhard Maisch
Aug 16, 2012·Heart Failure Reviews·Yang Hyun Cho, Hartzell V Schaff
Mar 19, 2013·Heart Failure Reviews·Bernhard Maisch
Aug 4, 2007·Pediatric Cardiology·G WendelinA Beitzke
Oct 7, 2009·Future Cardiology·Massimo ImazioYehuda Adler
Dec 23, 2015·Expert Review of Cardiovascular Therapy·Syed Wamique YusufPatrick T O'Gara
Aug 12, 2015·Nature Reviews. Cardiology·Massimo ImazioFiorenzo Gaita
Sep 3, 2011·American Heart Journal·Massimo ImazioYehuda Adler
Dec 4, 2015·Future Cardiology·Massimo Imazio, Fiorenzo Gaita
Dec 9, 2015·Herz·B Maisch, UNKNOWN European Society of Cardiology
Jan 29, 2008·International Journal of Cardiology·Massimo Imazio, Rita Trinchero
Oct 20, 2006·International Journal of Cardiology·Massimo Imazio, Rita Trinchero
Oct 12, 2012·Pediatric Cardiology·Alessandra ScardapaneLuciana Breda
Mar 24, 2016·Current Cardiology Reports·Alexander FardmanYehuda Adler
Jul 11, 2006·The American Journal of Cardiology·Antonio BrucatoDavid H Spodick
Oct 13, 2016·Hospital Pharmacy·Kristen Bova CampbellLindsey D Burgess
Aug 6, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Nicholas C Schwier
Sep 18, 2015·Frontiers in Plant Science·Ibrahim JantanSyed Nasir Abbas Bukhari
Sep 1, 2015·BMC Cardiovascular Disorders·Subodh VermaJan O Friedrich
Mar 7, 2015·Current Cardiology Reports·Massimo Imazio
Mar 17, 2015·Current Cardiology Reports·Paul C Cremer, Deborah H Kwon
Apr 25, 2016·Current Cardiology Reports·Massimo ImazioPhilippe Charron
Dec 18, 2014·The New England Journal of Medicine·Martin M LeWinter
Jul 6, 2016·Internal and Emergency Medicine·Ming-Xuan WangCi-Bo Huang
Jul 14, 2016·Journal of Community Hospital Internal Medicine Perspectives·Syed Raza ShahShehryar Shaikh
Mar 29, 2011·La Revue de médecine interne·G Geri, P Cacoub
Sep 3, 2013·The New England Journal of Medicine·Massimo ImazioUNKNOWN ICAP Investigators
Mar 30, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Kevin ChenVenu Menon

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.